Zobrazeno 1 - 10
of 291
pro vyhledávání: '"Kyongtae T Bae"'
Publikováno v:
Insights into Imaging, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Objective Past decades of research into contrast media injections and optimization thereof in radiology clinics have focused on scan acquisition parameters, patient-related factors, and contrast injection protocol variables. In this review,
Externí odkaz:
https://doaj.org/article/509fd013a5ee49308115dd2c0b6c066f
Autor:
Jose L Paredes, Abrahim I Orabi, Taimur Ahmad, Iman Benbourenane, Kimimasa Tobita, Sameh Tadros, Kyongtae T Bae, Sohail Z Husain
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92263 (2014)
In experimental models of pancreatic growth and recovery, changes in pancreatic size are assessed by euthanizing a large cohort of animals at varying time points and measuring organ mass. However, to ascertain this information in clinical practice, p
Externí odkaz:
https://doaj.org/article/1d9921000f32430cb12a2c71b28424e8
Autor:
Andreas D Kistler, Andreas L Serra, Justyna Siwy, Diane Poster, Fabienne Krauer, Vicente E Torres, Michal Mrug, Jared J Grantham, Kyongtae T Bae, James E Bost, William Mullen, Rudolf P Wüthrich, Harald Mischak, Arlene B Chapman
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53016 (2013)
Treatment options for autosomal dominant polycystic kidney disease (ADPKD) will likely become available in the near future, hence reliable diagnostic and prognostic biomarkers for the disease are strongly needed. Here, we aimed to define urinary prot
Externí odkaz:
https://doaj.org/article/7f1ebb423b8d46c0a90c2566f7c90e43
Autor:
Hyuk Huh, Yong Soo Kim, Wookyung Chung, Yong Lim Kim, Yaerim Kim, Seungyeup Han, Yeonsoon Jung, Ki Young Na, Kyu Beck Lee, Yun Kyu Oh, Hyeong Cheon Park, Seung Hyeok Han, Tae Hyun Yoo, Yeong Hoon Kim, Soo Wan Kim, Kang Wook Lee, Hayne Cho Park, Sung Gyun Kim, Hyunsuk Kim, Chang Hwa Lee, Kyongtae T. Bae, Kook Hwan Oh, Curie Ahn, Hyun Jin Ryu, Yong Chul Kim
Publikováno v:
Kidney Research and Clinical Practice, Vol 42, Iss 2, Pp 216-228 (2023)
Background Tolvaptan reduces height-adjusted total kidney volume (htTKV) and renal function decline in autosomal dominant polycystic kidney disease (ADPKD). This study was aimed at investigating the efficacy and safety of tolvaptan in Korean patients
Externí odkaz:
https://doaj.org/article/6097371022b54cc38061d29a236570c7
Autor:
Kenneth R. Hallows, Kaleab Z. Abebe, Hui Li, Biagio Saitta, Andrew D. Althouse, Kyongtae T. Bae, Christina M. Lalama, Dana C. Miskulin, Ronald D. Perrone, Stephen L. Seliger, Terry J. Watnick
Publikováno v:
Kidney International Reports. 8:467-477
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bdd6edf25ed93f0d0b5fc778a8d8547
https://doi.org/10.1016/j.ekir.2022.11.019
https://doi.org/10.1016/j.ekir.2022.11.019
Publikováno v:
Journal of the American Society of Nephrology. 33:1581-1589
Total kidney volume (TKV) is an important imaging biomarker in autosomal dominant polycystic kidney disease (ADPKD). Manual computation of TKV, particularly with the exclusion of exophytic cysts, is laborious and time consuming.We developed a fully a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8823a6dc604feec32300c5c3a4c07ffa
https://doi.org/10.1681/asn.2021111400
https://doi.org/10.1681/asn.2021111400
Autor:
Adriana V. Gregory, Fouad T. Chebib, Bhavya Poudyal, Heather L. Holmes, Alan S.L. Yu, Douglas P. Landsittel, Kyongtae T. Bae, Arlene B. Chapman, Rahbari-Oskoui Frederic, Michal Mrug, William M. Bennett, Peter C. Harris, Bradley J. Erickson, Vicente E. Torres, Timothy L. Kline
Publikováno v:
Kidney International.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e925e7bfd585428f4758478cd679db65
https://doi.org/10.1016/j.kint.2023.01.010
https://doi.org/10.1016/j.kint.2023.01.010
Autor:
Christina M. Lalama, Peter C. Harris, Ronald D. Perrone, Cheng Tao, Stephen L. Seliger, Kaleab Z. Abebe, Terry Watnick, Kyongtae T. Bae, Kenneth R. Hallows, Dana C. Miskulin, Andrew D. Althouse
Publikováno v:
Kidney International. 100:684-696
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by growth of kidney cysts and glomerular filtration rate (GFR) decline. Metformin was found to impact cystogenesis in preclinical models of polycystic disease, is generally conside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2018f3b0eee0a72dfc767e19d18555
https://doi.org/10.1016/j.kint.2021.06.013
https://doi.org/10.1016/j.kint.2021.06.013
Autor:
Kenneth R. Hallows, Andrew D. Althouse, Stephen L. Seliger, Ronald D. Perrone, Kyongtae T. Bae, Kaleab Z. Abebe, Hui Li, Terry Watnick, Biagio Saitta, Dana C. Miskulin
Publikováno v:
Kidney360
BACKGROUND: Recent work suggests that dysregulated cellular metabolism may play a key role in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD). The TAME-PKD clinical trial is testing the safety, tolerability, and efficacy of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2026031aa9e9e084a3d82814277821b8
https://doi.org/10.34067/kid.0005962020
https://doi.org/10.34067/kid.0005962020
Autor:
Shiqin Zhang, Kyongtae T. Bae, Vicente E. Torres, William M. Bennett, Douglas Landsittel, Frederic F. Rahbari-Oskoui, Jared J. Grantham, Jason R. Stubbs, Pengcheng Lu, Mireille El Ters, Jonathan D. Mahnken, Darren P. Wallace, Peter C. Harris, Michal Mrug, Alan S.L. Yu, Arlene B. Chapman
Publikováno v:
Kidney International Reports, Vol 6, Iss 4, Pp 953-961 (2021)
Kidney International Reports
Kidney International Reports
Introduction Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst growth and a loss of functioning renal mass, but a decline in glomerular filtration rate (GFR) and onset of end-stage renal disease (ESRD) occur la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89bafa5b87c66b4a276caf01d608fa30
https://doi.org/10.1016/j.ekir.2021.01.004
https://doi.org/10.1016/j.ekir.2021.01.004